PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsobstructive lung diseases
MeSH D008173 - obstructive lung diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D008171:Lung diseases
$
Success rate
D008173: 
Obstructive lung diseases
$
Success rate
D001991:Bronchitis
D029424:Chronic obstructive pulmonary disease
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaAcetaminophen, Hydrocodone Allay  1989-01-13   
Acetaminophen, Hydrocodone Hydrocodone Acetaminophen  1988-04-21   
PadagisPseudoephedrine, Hydrocodone, Chlorpheniramine Hydrocodone Bitartrate, Chlorpheniramine Pseudoephedrine  2014-04-29   
Pseudoephedrine, Hydrocodone Hydrocodone Pseudoephedrine  2014-04-29   
Mayne GroupPseudoephedrine, Hydrocodone, Chlorpheniramine Hydrocodone Bitartrate, Chlorpheniramine Pseudoephedrine  2015-08-03   
Pseudoephedrine, Hydrocodone Hydrocodone Pseudoephedrine  2015-11-17   
Johnson & JohnsonAcetaminophen, Hydrocodone Tycolet  1986-08-27   
SandozAcetaminophen, Hydrocodone Hydrocodone Acetaminophen  1997-01-27   
AbbVieAcetaminophen, Hydrocodone Vicodin  1996-09-23   
UCBAcetaminophen, Hydrocodone Co-gesic  1982-05-03   
Acetaminophen, Hydrocodone Hydrocodone Acetaminophen  1996-11-21   
Acetaminophen, Hydrocodone Lortab  1996-01-26   
Hydrocodone, Chlorpheniramine Tussionex Pennkinetic  1987-12-31   
AlpharmaHydrocodone, Phenylpropanolamine Codamine  2000-09-29   
Genus LifesciencesAcetaminophen, Hydrocodone Hydrocodone Acetaminophen  2011-07-19   
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
46%
6/13
Phase 3
10%
1/10
Approved: 1Overall Success rate: 5%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Mayne Group
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use